EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

Type I interferon signalling and interferon‐responsive microglia in health and disease

Jose P Lopez-Atalaya iD, Aysha M Bhojwani-Cabrera

The FEBS Journal · 2025-11 · 292 (22) · 5921-5940

DOI: 10.1111/febs.70126 ↗

At a glance

Übersichtsarbeit in The FEBS Journal, published online on 2025-04-29. Written by Jose P Lopez-Atalaya and 1 co-authors. Institution: Instituto de Neurociencias, Consejo Superior de Investigaciones Científicas, Universidad Miguel Hernández, Alicante, Spain. Major MEDLINE topics: Microglia, Interferon Type I, Signal Transduction, Neurodegenerative Diseases. Cited 26 times so far (Crossref); 197 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: MCIU/AEI/10.13039/501100011033, Generalitat Valenciana.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Recent evidence suggests that type I interferon (IFN‐I) signalling extends beyond its canonical roles in antiviral defence and immunomodulation. Over the past decade, dysregulated IFN‐I signalling has been linked to genetic disorders and neurodegenerative diseases, where it may contribute to neurological impairments. Microglia have emerged as key mediators of IFN‐I responses in the central nervous system. A distinct transcriptional state responsive to interferons has recently been identified in microglia. The activation of the IFN‐I pathway in these cells is now recognised as pivotal in both development and neurodegeneration. This review is divided into two main sections: the first examines the broader role of IFN‐I signalling in the central nervous system, particularly its contribution to neurological dysfunction; the second focuses on the specific state of interferon‐responsive microglia, exploring its mechanisms and relevance in neurodegenerative conditions. Finally, we discuss how these areas intersect and their implications for both healthy and diseased states.

Subjects

MeSH terms (MEDLINE)

MicrogliaInterferon Type ISignal TransductionNeurodegenerative DiseasesHumansAnimalsCentral Nervous System

Author keywords

braininterferon‐responsive microgliamicroglianeuroinflammationtype‐I interferon

Substances

Interferon Type I

Authors and institutions

  • Instituto de Neurociencias, Consejo Superior de Investigaciones Científicas, Universidad Miguel Hernández, Alicante, Spain.

ORCID profiles: Jose P Lopez-Atalaya

Funding

  • MCIU/AEI/10.13039/501100011033
  • Generalitat Valenciana

Cite

APA

Lopez-Atalaya, J. P., & Bhojwani-Cabrera, A. M. (2025). Type I interferon signalling and interferon‐responsive microglia in health and disease. The FEBS Journal, 292(22), 5921-5940. https://doi.org/10.1111/febs.70126

Vancouver

Lopez-Atalaya JP, Bhojwani-Cabrera AM. Type I interferon signalling and interferon‐responsive microglia in health and disease. The FEBS Journal. 2025;292(22):5921-5940. doi:10.1111/febs.70126

BibTeX
@article{LopezAtalaya2025,
  author = {Lopez-Atalaya, Jose P and Bhojwani-Cabrera, Aysha M},
  title = {Type I interferon signalling and interferon‐responsive microglia in health and disease},
  journal = {The FEBS Journal},
  year = {2025},
  volume = {292},
  number = {22},
  pages = {5921--5940},
  doi = {10.1111/febs.70126}
}
Start for free →